Glycoconjugate Journal

, Volume 13, Issue 5, pp 717–726 | Cite as

Benzyl-N-acetyl-α-d-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation

  • Philippe Delannoy
  • Isabelle Kim
  • Nathalie Emery
  • Carmen de Bolos
  • Andre Verbert
  • Pierre Degand
  • Guillemette Huet


We have analysed the mucins synthesized by the HT-29 MTX cell subpopulation, derived from the HT-29 human colon carcinoma cells through a selective pressure with methotrexate (Lesuffleuret al., 1990,Cancer Res50: 6334–43), in the presence of benzyl-N-acetyl-α-galactosaminide (GalNAcα-O-benzyl), which is a potential competitive inhibitor of the β1,3-galactosyltransferase that synthesizes the T-antigen. The main observation was a 13-fold decrease in the sialic acid content of mucins after 24 h of exposure to 5mm GalNAcα-O-benzyl. This effect was accompanied by an increased reactivity of these mucins to peanut lectin, testifying to the higher amount of T-antigen. The second observation was a decrease in the secretion of the mucins by GalNAcα-O-benzyl treated cells. The decrease in mucin sialyation was achieved through thein situ β-galactosylation of GalNAcα-O-benzyl into Galβ1–3GalNAcα-O-benzyl, which acts as a competitive substrate of Galβ1–3GalNAc α2,3-sialyltransferase, as shown by the intracellular accumulation of NeuAcα2–3Galβ1–3GalNAcα-O-benzyl in treated cells.


HT-29 cells mucins aryl-glycosides O-glycosylation sialyltransferases 



bovine submaxillary mucin




sodium phosphate 10mm, NaCl 0.15m, pH 7.4 buffer




Tris/HCl 10mm, NaCl 0.15m, pH 7.4 buffer


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bhavanandan VP (1991)Glycobiology 1: 493–503.Google Scholar
  2. 2.
    Rose MC (1992)Am Physiol Soc 263: L413–17.Google Scholar
  3. 3.
    Kurosaka A, Nakajima H, Funakoshi I, Matsuyama M, Nagayo T, Yamashina I (1983)J Biol Chem 258: 11594–98.Google Scholar
  4. 4.
    Kim YS (1992)J Cell Biochem Suppl 16G: 91–96.Google Scholar
  5. 5.
    Varki A (1993)Glycobiology 3: 97–130.Google Scholar
  6. 6.
    Pinto M, Appay MD, Simon-Assmann P, Chevalier G, Drocopoli N, Fogh J, Zweibaum A (1982)Biol Cell 44: 193–96.Google Scholar
  7. 7.
    Augeron C, Laboisse CL (1984)Cancer Res 44: 3961–69.Google Scholar
  8. 8.
    Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A (1990)Cancer Res 50: 6334–43.Google Scholar
  9. 9.
    Maoret JJ, Font J, Augeron C, Codogno P, Baury C, Aubery M, Laboisse CL (1989)Biochem J 258: 793–99.Google Scholar
  10. 10.
    Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A (1991)Int J Cancer 49: 721–30.Google Scholar
  11. 11.
    Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A (1993)J Cell Sci 106: 771–83.Google Scholar
  12. 12.
    Kuan SF, Byrd JC, Basbaum C, Kim YS (1989)J Biol Chem 264: 19271–77.Google Scholar
  13. 13.
    Huang J, Byrd JC, Yoon WH, Kim YS (1992)Oncol Res 4: 507–15.Google Scholar
  14. 14.
    DiIulio NA, Bhavanandan VP (1995)Glycobiology 5: 195–99.Google Scholar
  15. 15.
    Duk M, Steuden I, Dus D, Radzikowski C, Lisowska E (1992)Glycoconjugate J 9: 148–53.Google Scholar
  16. 16.
    Steuden I, Duk M, Czerwinski M, Radzikowski C, Lisowska E (1985)Glycoconjugate J 2: 303–14.Google Scholar
  17. 17.
    Huet G, Kim I, De Bolos C, Lo-Guidice JM, Moreau O, Hemon B, Richet C, Delannoy P, Real FX, Degand P (1995)J Cell Sci 108: 1275–85.Google Scholar
  18. 18.
    Houdret N, Perini JM, Galabert C, Scharfman A, Humbert P, Lamblin G, Roussel P (1986)Biochim Biophys Acta 880: 54–61.Google Scholar
  19. 19.
    De Jong JGN, Wevers RA, Sambeek RLV (1992)Clin Chem 38: 803–7.Google Scholar
  20. 20.
    Lamblin G, Boersma A, Klein A, Roussel P, Van Halbeek H, Vliegenthart JFG (1984)J Biol Chem 259: 9051–58.Google Scholar
  21. 21.
    Lo-Guidice JM, Wieruszeski JM, Lemoine J, Verbert A, Roussel P, Lamblin G (1994)J Biol Chem 269: 18794–813.Google Scholar
  22. 22.
    Laemmli UK (1970)Nature 227: 680–81.Google Scholar
  23. 23.
    Vaessen RTMJ, Kreike J, Groot GSP (1981)FEBS Lett 124: 193–96.Google Scholar
  24. 24.
    Peterson GL (1977)Anal Biochem 83: 346–56.Google Scholar
  25. 25.
    Dall'Olio F, Malagolini N, Serafini-Cessi F (1992)Biochem Biophys Res Commun 184: 1405–10.Google Scholar
  26. 26.
    Delannoy P, Pelczar H, Vandamme V, Verbert A (1993)Glycoconjugate J 10: 91–98.Google Scholar
  27. 27.
    Vandamme V, Cazlaris H, Le Marer N, Laudet V, Lagrou C, Verbert A, Delannoy P (1992)Biochimie 74: 89–100.Google Scholar
  28. 28.
    Schachter H, Brockhausen I (1989) InMucus and Related Topics (Chantler E, Ratcliffe NA, eds) pp. 1–26, Cambridge: Society for Experimental Biology.Google Scholar
  29. 29.
    Dall'Olio F, Malagolini N, Guerrini S, Serafini-Cessi F (1993)Biochem Biophys Res Commun 196: 714–20.Google Scholar
  30. 30.
    Capon C, Laboisse CL, Wieruszeski JM, Maoret JJ, Augeron C, Fournet B (1992)J Biol Chem 267: 19248–57.Google Scholar
  31. 31.
    Joziasse DH, Bergh MLE, ter Hart HGJ, Koppen PL, Hooghwinkel GJM, Van den Eijnden DH (1985)J Biol Chem 260: 4941–51.Google Scholar
  32. 32.
    Kuhns W, Rutz V, Paulsen H, Matta KL, Baker MA, Barner M, Granovsky M, Brockhausen I (1993)Glycoconjugate J 10: 381–94.Google Scholar

Copyright information

© Chapman & Hall 1996

Authors and Affiliations

  • Philippe Delannoy
    • 1
  • Isabelle Kim
    • 2
  • Nathalie Emery
    • 2
  • Carmen de Bolos
    • 3
  • Andre Verbert
    • 1
  • Pierre Degand
    • 2
  • Guillemette Huet
    • 2
  1. 1.Laboratoire de Chimie Biologique, Unité Mixte de Recherche du CNRS no 111Université des Sciences et Technologies de LilleVilleneuve d'AscqFrance
  2. 2.INSERM U-377LilleFrance
  3. 3.Institut Municipal d'Investigacio MedicaUniversitat Autonoma de BarcelonaSpain

Personalised recommendations